Sagility India Ltd

Sagility India IPO

Sagility India Ltd

₹19,000 /500 sharesMinimum investment

IPO listing details

Listed on
12 Nov '24
Issue price
₹51.00
Listing price
₹31.06
Listing gains
-₹19.94 (39.10%)
Exchange
--

IPO details

Minimum investment
₹19,000
Price range
₹38 - ₹51
Lot size
1
Issue size
2,106.60 Cr
Face value
10
IPO document

Subscription rate

Qualified Institutional Buyers3.52x
Non-Institutional Investor1.91x
Retail Individual Investor4.07x
Employees3.71x
Total3.18x
As of 07 Nov'24, 05:00 PM

Schedule

27 May 2025
IPO open date
28 May 2025
IPO close date
8 Nov 2024
Allotment date
8 Nov 2024
Funds unblock or debit
12 Nov 2024
Tentative listing date

About

Sagility India is a healthcare solutions and service provider, focusing on US health insurance companies (payers) and healthcare providers, including hospitals, physicians, and medical device companies (providers). For the payers, Sagility India provides services, such as core benefits administration and clinical support, including claims processing, payment accuracy, clinical management, and related services. For the providers, they offer revenue cycle management services. Sagility India also extends some of these services to pharmacy benefit managers (PBMs), who oversee prescription drug management for insured individuals within health plans. ;
Founded in
2021
MD/CEO
Mr. Ramesh Gopalan
Parent organisation
Sagility India Ltd

Sagility India Financials

Revenue
Total Assets
Profit
All values are in ₹ Cr
9234,2184,754202220232024

Strengths & Risks

Strengths
Risks
Sagility India claims to offer technology-driven services to both payer and provider clients and delivers comprehensive, end-to-end solutions that include front- and back-office healthcare services.
The company claims to have developed a range of proprietary tools and platforms that enhance its service offerings, support the full operational needs of payer clients, and manage revenue cycles for healthcare provider clients. According to the company, these platforms use advanced technologies, including robotic process automation (RPA), analytics, and artificial intelligence (AI).
In March 2024, Sagility India expanded its technology capabilities by acquiring BirchAI, a healthcare technology firm specialising in cloud-based, generative AI solutions.
Sagility India operates from 30 locations across five countries: the U.S., Colombia, Jamaica, India, and the Philippines.
The company has observed a consistent increase in revenue from operations over the years. Revenue from operations increased from Rs 923.41 crore in FY22 to Rs 4,218.41 crore in FY23 to Rs 4,753.56 crore in FY24
Sagility India majorly focuses on the US healthcare industry. Any adverse developments in the healthcare landscape of the US, a decline in the demand for the company’s services, or any inability to expand its operations can be detrimental to the company’s business performance.
The company’s top 10 customers in the US contributed Rs 4,345.18 crore (91.41%), Rs 3,825.16 crore (90.68%), and Rs 849.07 crore (91.95%) to the revenue from operations in FY24, FY23, and FY22, respectively. Should the company lose any of these key clients or fail to maintain cordial relationships with them, it could adversely affect the company’s finances and operations.
The company, its subsidiaries, and directors are involved in some legal proceedings. Any adverse judgment in any of these cases could be detrimental to the company’s business prospects.
The company’s largest assets consist of goodwill and other intangible assets. Any impairment to these assets can hurt the company’s reputation and financial health.
The company's success depends on its ability to keep up with the latest technological trends. Therefore, any failure to adequately invest in technology, achieve desired returns on these investments, or address errors or disruptions in its tools and platforms can adversely affect the company’s business operations. Any technological changes can also render its services obsolete, potentially impacting its business stability.
The company reported a loss of Rs 4.67 crore for the period from July 28, 2021, to March 31, 2022.
As of March 31, 2024, Sagility India’s outstanding borrowings (current and non-current) totalled Rs 1,933.52 crore. Any inability to service these borrowings could negatively affect the company’s financial standing.

Application details

For Sagility India IPO, eligible investors can apply as Regular & Employee.

Apply asPrice bandApply rangeLot size
Regular₹28 - ₹30Upto ₹2 Lakhs500
Employee₹26 - ₹28Upto ₹2 Lakhs500
High Networth Individual₹28 - ₹30₹2 - ₹5 Lakhs500

Frequently Asked Questions